Maternal malnutrition is keratomalacia risk factor

Article

Keratomalacia can be linked to lower socioeconomic status, poor maternal nutrition, and inadequate breastfeeding.

Keratomalacia can be linked to lower socioeconomic status, poor maternal nutrition, and inadequate breastfeeding, according to a paper in the journal Cornea.

Dr Noopur Gupta et al., Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India, studied the case records of children under 6 months of aged suffering from keratomalacia from June 2007 to April 2010.

Parameters assessed included age, sex, anthropometry, nutritional status, socioeconomic status, antenatal history, maternal nutrition, systemic associations, immunization and dietary history. Comprehensive ocular examination was completed and consisted of ocular adnexa, conjunctiva, cornea and anterior chamber.

Of the children included in the study, 88% had protein energy-associated malnutrition, 94% belonged to poor families and 75% were not sufficiently immunized. In 100% of keratomalacia patients, inadequate breastfeeding was the main cause.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.